The known and missing links between Toxoplasma gondii and schizophrenia

被引:53
|
作者
Elsheikha, Hany M. [1 ]
Busselberg, Dietrich [2 ]
Zhu, Xing-Quan [3 ]
机构
[1] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Loughborough LE12 5RD, Leics, England
[2] Qatar Fdn Educ City, Weill Cornell Med Coll Qatar, POB 24144, Doha, Qatar
[3] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China
基金
中国国家自然科学基金;
关键词
Toxoplasma gondii; Schizophrenia; Mental illness; Psychosis; Host-pathogen interaction; OBSESSIVE-COMPULSIVE DISORDER; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; C-REACTIVE PROTEIN; BIPOLAR DISORDER; INFECTED MICE; OXIDATIVE STRESS; INTERFERON-GAMMA; CELL-CULTURES; DOPAMINE;
D O I
10.1007/s11011-016-9822-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Toxoplasma gondii, an intracellular protozoan parasite, has a striking predilection for infecting the Central Nervous System and has been linked to an increased incidence of a number of psychiatric diseases. Several in vitro and in vivo studies have shown that T. gondii infection can affect the structure, bioenergetics and function of brain cells, and alters several host cell processes, including dopaminergic, tryptophan-kynurenine, GABAergic, AKT1, Jak/STAT, and vasopressinergic pathways. These mechanisms underlying the neuropathology of latent toxoplasmosis seem to operate also in schizophrenia, supporting the link between the two disorders. Better understanding of the intricate parasite-neuroglial communications holds the key to unlocking the mystery of T. gondii-mediated schizophrenia and offers substantial prospects for the development of disease-modifying therapies.
引用
收藏
页码:749 / 759
页数:11
相关论文
共 50 条
  • [31] Toxoplasma gondii infection in schizophrenia and associated clinical features
    Esshili, Awatef
    Thabet, Sihem
    Jemli, Achraf
    Trifa, Fatma
    Mechri, Anouar
    Zaafrane, Ferid
    Gaha, Lotfi
    Juckel, Georg
    Babba, Hamouda
    Jrad, Besma Bel Hadj
    PSYCHIATRY RESEARCH, 2016, 245 : 327 - 332
  • [32] The schizophrenia and Toxoplasma gondii connection:: Infectious, immune or both?
    Tamer, Gulden Sonmez
    Dundar, Devrim
    Yalug, Irem
    Caliskan, Seyda
    Yazar, Suleyman
    Aker, Ahmet
    ADVANCES IN THERAPY, 2008, 25 (07) : 703 - 709
  • [33] Early infections of Toxoplasma gondii and the later development of schizophrenia
    Mortensen, Preben Bo
    Norgaard-Pedersen, Bent
    Waltoft, Berit L.
    Sorensen, Tina L.
    Hougaard, David
    Yolken, Robert H.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (03) : 741 - 744
  • [34] Interaction between Toxoplasma gondii and enterocyte
    Bout, D
    Moretto, M
    Dimier-Poisson, I
    Gatel, DB
    IMMUNOBIOLOGY, 1999, 201 (02) : 225 - 228
  • [35] CLINICAL DIFFERENCES BETWEEN TOXOPLASMA GONDII SEROPOSITIVE AND SERONEGATIVE SCHIZOPHRENIA PATIENTS IN CZECH AND INTERNATIONAL STUDIES
    Holub, D.
    Motlova, L. Bankovska
    Dragomirecka, E.
    Rodriguez, M.
    Preiss, M.
    Novak, T.
    Cermak, J.
    Horacek, J.
    Libiger, J.
    Flegr, J.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [36] Links Between Toxoplasma gondii IgG Seropositivity and Serointensity and Measures of Geriatric Frailty, Depression and Cognitive Impairment
    Postolache, Teodor
    Laffon, Blanca
    Mohyuddin, Hira
    Pasaro, Eduardo
    Marcos-Perez, Diego
    Constantine, Niel
    Dagdag, Aline
    Stiller, John W.
    Ortmeyer, Heidi
    Mohyuddin, Iqra
    Marano, Christopher
    Lowry, Christopher A.
    Brenner, Lisa A.
    Valdiglesias, Vanessa
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S152 - S153
  • [37] Prevalence of antibodies to Toxoplasma gondii in patients with schizophrenia and mood disorders
    Nascimento, Fernanda Santos
    Dantas, Clarissa de Rosalmeida
    Netto, Mario Pincelli
    Mella, Lucas F. B.
    Suzuki, Lisandra Akemi
    Banzato, Claudio E. M.
    Rossi, Claudio Lucio
    SCHIZOPHRENIA RESEARCH, 2012, 142 (1-3) : 244 - 245
  • [38] Toxoplasma gondii as a Risk Factor for Developing Schizophrenia: Review of the Literature
    Botero-Rodriguez, Felipe
    Zarate-Velasco, Ana Maria
    Martinez, Damaris Cote
    Gomez-Restrepo, Carlos
    Osorio, Andres Duarte
    UNIVERSITAS MEDICA, 2023, 64 (02):
  • [39] Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii
    Bachmann, S
    Schröder, J
    Bottmer, C
    Torrey, EF
    Yolken, RH
    PSYCHOPATHOLOGY, 2005, 38 (02) : 87 - 90
  • [40] Toxoplasma gondii and Cognitive Deficits in Schizophrenia: An Animal Model Perspective
    Kannan, Geetha
    Pletnikov, Mikhail V.
    SCHIZOPHRENIA BULLETIN, 2012, 38 (06) : 1155 - 1161